Clinical Study
Clinicopathological Proficiency in the Diagnosis of Kaposi's Sarcoma
Table 2
Distribution by anatomical sites of Kaposi’s sarcoma: HIV-positive versus unknown serostatus.
| Site | Males HIV positive (%) | Females HIV positive (%) | Total HIV positive (%) | Males HIV status unknown (%) | Females HIV status unknown (%) | Total HIV status unknown (%) |
| Head | 7 (8.8)* | 4 (7.0)* | 11 (8.0)† | 9 (23.7)* | 9 (24.3)* | 18 (24.0)† | Trunk | 5 (6.3) | 1 (1.8) | 6 (4.4) | 3 (7.9) | | 3 (4.0) | Upper limbs | 4 (5.0) | 1 (1.8) | 5 (3.6) | 3 (7.9) | 3 (8.1) | 6 (8.0) | Lower limbs | 34 (42.5) | 23 (40.3) | 57 (41.6) | 17 (44.7) | 18 (48.6) | 35 (46.7) | Perineal | 1 (1.3) | 4 (7.0) | 5 (3.6) | 1 (2.6) | 2 (5.4) | 3 (4.0) | Disseminated | 29 (36.2) | 24 (42.1) | 53 (38.7)† | 5 (13.2) | 5 (13.5) | 10 (13.3)† | Unknown | 4 (4.8)** | 20 (26.0)** | 24 (14.9)** | 14 (36.8)** | 11 (22.9)** | 25 (25.0)** |
| Total | 84 | 77 | 161 | 52 | 48 | 100 |
|
|
*% of the total number of known anatomical sites; ** % of the total number of cases; statistically significant 95% confidence intervals (CIs).
|